Credit Suisse’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-150,752
| Closed | -$3.56M | – | 3047 |
|
|
2023
Q4 | $3.56M | Sell |
150,752
-10,913
| -7% | -$258K | ﹤0.01% | 1527 |
|
|
2023
Q3 | $2.41M | Sell |
161,665
-10,392
| -6% | -$155K | ﹤0.01% | 1701 |
|
|
2023
Q2 | $1.88M | Buy |
172,057
+106,311
| +162% | +$1.16M | ﹤0.01% | 1939 |
|
|
2023
Q1 | $573K | Buy |
+65,746
| New | +$573K | ﹤0.01% | 2661 |
|
|
2021
Q2 | – | Sell |
-35,269
| Closed | -$160K | – | 3685 |
|
|
2021
Q1 | $160K | Sell |
35,269
-4,197
| -11% | -$19K | ﹤0.01% | 3301 |
|
|
2020
Q4 | $226K | Buy |
+39,466
| New | +$226K | ﹤0.01% | 3213 |
|
|
2020
Q3 | – | Sell |
-490,223
| Closed | -$1.71M | – | 3331 |
|
|
2020
Q2 | $1.71M | Sell |
490,223
-122,067
| -20% | -$426K | ﹤0.01% | 1963 |
|
|
2020
Q1 | $907K | Buy |
612,290
+576,781
| +1,624% | +$854K | ﹤0.01% | 2175 |
|
|
2019
Q4 | $70K | Sell |
35,509
-11,085
| -24% | -$21.9K | ﹤0.01% | 3420 |
|
|
2019
Q3 | $238K | Buy |
46,594
+3,005
| +7% | +$15.3K | ﹤0.01% | 3134 |
|
|
2019
Q2 | $311K | Sell |
43,589
-786,518
| -95% | -$5.61M | ﹤0.01% | 3028 |
|
|
2019
Q1 | $11M | Buy |
830,107
+789,594
| +1,949% | +$10.5M | 0.01% | 905 |
|
|
2018
Q4 | $319K | Sell |
40,513
-430
| -1% | -$3.39K | ﹤0.01% | 2961 |
|
|
2018
Q3 | $453K | Sell |
40,943
-17,209
| -30% | -$190K | ﹤0.01% | 2893 |
|
|
2018
Q2 | $780K | Buy |
58,152
+36,663
| +171% | +$492K | ﹤0.01% | 2745 |
|
|
2018
Q1 | $279K | Sell |
21,489
-7,946
| -27% | -$103K | ﹤0.01% | 3173 |
|
|
2017
Q4 | $271K | Buy |
29,435
+13,593
| +86% | +$125K | ﹤0.01% | 3165 |
|
|
2017
Q3 | $127K | Buy |
+15,842
| New | +$127K | ﹤0.01% | 3558 |
|